Abdala
Global outcry after Venezuela financially blocked from COVAX initiative

Last week, the Venezuelan government announced that the Union Bank of Switzerland blocked its latest payments of 10 million USD towards the COVAX initiative for acquiring COVID-19 vaccines

COVID-19 vaccine: Cuba hopeful about indigenous vaccine in Phase 3 trial

In previous trials, the Soberana 02 vaccine candidate generated antibody response in about 80% of the people who were administered two doses

Around the World in 8 minutes: Mumia Abu-Jamal’s struggle for justice and more

In this episode of Around the World in 8 Minutes, we look at the struggle of Mumia Abu-Jamal for his rights and health, the development of various vaccine candidates in Cuba and the global mobilizations and preparations ahead of International Women’s Day

Cuba’s anti-COVID vaccine candidate Soberana 02 begins phase III clinical trials

In this final and decisive phase of trials, the objective is to evaluate the efficacy, safety and immunogenicity of Soberana 02. If the vaccine produces fruitful results, Cuba will become the first country in the Latin American and the Caribbean region to develop its own vaccine

Cuba is one step closer to launching its own anti-COVID vaccines

Cuba is the only country in the Latin American and the Caribbean region that is working to develop its own vaccines against COVID-19. The country has four vaccine candidates. Two of them, Soberana 02 of the Finlay Vaccine Institute (IFV) and Abdala of the Center for Genetic Engineering and Biotechnology (CIGB), will begin the third phase of clinical trials in March

    × To Subscribe